Evidence map›Paper›PMID 26352325›Full record

ArticleGlia2016

Characterization of glucose-related metabolic pathways in differentiated rat oligodendrocyte lineage cells.

Ana I Amaral, Mussie G Hadera, Joana M Tavares, Mark R N Kotter, Ursula Sonnewald

Open access · hybridAbstract read
In one paragraph

Article in Glia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 89 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. An Overview of Oligodendrocyte Metabolism.Advances in neurobiology · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Isotope tracing in health and disease.Current opinion in biotechnology · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Ana I AmaralAnne McLaren Laboratory, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, United Kingdom.
Mussie G HaderaDepartment of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, 7491, Norway.
Joana M TavaresAnne McLaren Laboratory, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, United Kingdom.
Mark R N KotterAnne McLaren Laboratory, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, United Kingdom.
Ursula SonnewaldDepartment of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, 7491, Norway.
Medical Research Council · GBNorwegian University of Science and Technology · NOUniversity of Cambridge · GBUniversity of Copenhagen · DK

Funding

Medical Research CouncilWellcome Trust 97922
6 · The paper itself

Abstract

Although oligodendrocytes constitute a significant proportion of cells in the central nervous system (CNS), little is known about their intermediary metabolism. We have, therefore, characterized metabolic functions of primary oligodendrocyte precursor cell cultures at late stages of differentiation using isotope-labelled metabolites. We report that differentiated oligodendrocyte lineage cells avidly metabolize glucose in the cytosol and pyruvate derived from glucose in the mitochondria. The labelling patterns of metabolites obtained after incubation with [1,2-(13)C]glucose demonstrated that the pentose phosphate pathway (PPP) is highly active in oligodendrocytes (approximately 10% of glucose is metabolized via the PPP as indicated by labelling patterns in phosphoenolpyruvate). Mass spectrometry and magnetic resonance spectroscopy analyses of metabolites after incubation of cells with [1-(13)C]lactate or [1,2-(13)C]glucose, respectively, demonstrated that anaplerotic pyruvate carboxylation, which was thought to be exclusive to astrocytes, is also active in oligodendrocytes. Using [1,2-(13)C]acetate, we show that oligodendrocytes convert acetate into acetyl CoA which is metabolized in the tricarboxylic acid cycle. Analysis of labelling patterns of alanine after incubation of cells with [1,2-(13)C]acetate and [1,2-(13)C]glucose showed catabolic oxidation of malate or oxaloacetate. In conclusion, we report that oligodendrocyte lineage cells at late differentiation stages are metabolically highly active cells that are likely to contribute considerably to the metabolic activity of the CNS.

Indexed as

AcetatesAcetyl Coenzyme AAnimalsCarbon RadioisotopesCells, CulturedCitric Acid CycleCytosolGlucoseLactic AcidMalatesMitochondriaNeural Stem CellsOligodendrogliaOxaloacetic AcidPentose Phosphate PathwayPhosphoenolpyruvateAcetatesAcetyl Coenzyme ACarbon RadioisotopesGlucoseLactic AcidMalatesmalic acidOxaloacetic AcidPhosphoenolpyruvatePyruvic AcidRadiopharmaceuticals13Cacetateenergy metabolismglucoseglycolysismitochondriaoligodendrogliapyruvate carboxylation

Identifiers

PMID26352325
PMCPMC4832329
OpenAlexW2167725120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.